Chitosan Interferon-γ Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses

The use of chitosan nanoparticles as carriers for expression plasmids represents a major improvement in gene expression technology. We demonstrated previously that treatment with chitosan interferon-γ (IFN-γ) plasmid deoxyribonucleic acid (DNA) nanoparticles (chitosan interferon-γ nanogene [CIN]) le...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Xiaoyuan, Hellermann, Gary R, Zhang, Weidong, Jena, Prasanna, Kumar, Mukesh, Behera, Aruna, Behera, Sumita, Lockey, Richard, Mohapatra, Shyam S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868869/
https://www.ncbi.nlm.nih.gov/pubmed/20525130
http://dx.doi.org/10.1186/1710-1492-4-3-95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868869/
https://www.ncbi.nlm.nih.gov/pubmed/20525130
http://dx.doi.org/10.1186/1710-1492-4-3-95

Ejemplares similares